MicroRNAs of the immune system: Roles in inflammation and cancer

Annals of the New York Academy of Sciences

Volumn 1183, Issue , 2010, Pages 183-194

  Davidson Moncada, Jan ^a   Papavasiliou, F Nina ^a   Tam, Wayne ^b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Cancer; Immune system; Inflammation; MiRNA

Indexed keywords

CYTIDINE DEAMINASE; DICER; EXPORTIN 5; MESSENGER RNA; MICRORNA; RAN PROTEIN; RNA INDUCED SILENCING COMPLEX; RNA POLYMERASE II; UNTRANSLATED RNA;

ADAPTIVE IMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE DIFFERENTIATION; CARCINOGENESIS; GENE EXPRESSION; GERMINAL CENTER; HEMATOPOIESIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; REGULATORY MECHANISM; REVIEW; RNA SYNTHESIS;

ANIMALIA; EUKARYOTA; FUNGI;

EID: 75749145045     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05121.x     Document Type: Review

References (100)

1. Napoli, C., C. Lemieux & R. Jorgensen. 1990. Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous genes in trans. Plant Cell. 2: 279-289.
2. Romano, N. & G. Macino. 1992. Quelling: Transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol. Microbiol. 6: 3343-3353.
3. Guo, S.&K.J.Kemphues. 1995. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81: 611-620.
4. Fire, A. et al. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature. 391: 806-811. (Pubitemid 28099681)
5. Lee, R.C., R.L. Feinbaum & V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
6. Wightman, B., I. Ha & G. Ruvkun. 1993. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4mediates temporal pattern formation in C. elegans. Cell 75: 855-862.
7. Lagos-Quintana, M. et al. 2001. Identification of novel genes coding for small expressedRNAs. Science 294: 853-858.
8. Bernstein, E. et al. 2003. Dicer is essential for mouse development. Nat. Genet. 35: 215-217.
9. Wienholds, E. & R.H. Plasterk. 2005. MicroRNA function in animal development. FEBS Lett. 579: 5911-5922.
10. Murchison, E.P. et al. 2005. Characterization of Dicerdeficient murine embryonic stem cells. Proc. Natl. Acad. Sci. USA 102: 12135-12140.
11. Lynam-Lennon, N., S.G. Maher & J.V. Reynolds. 2009. The roles of microRNA in cancer and apoptosis. Biol Rev Cambridge Philos Soc. 84: 55-71.
12. Griffiths-Jones, S. et al. 2008. miRBase: Tools for microRNA genomics. Nucleic Acids. Res. 36: D154-158.
13. Pillai, R.S., S.N. Bhattacharyya & W. Filipowicz. 2007. Repression of protein synthesis by miRNAs: How many mechanisms? Trends Cell. Biol. 17: 118-126.
14. Lewis, B.P., C.B. Burge & D.P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
15. Lim, L.P. et al. 2003. Vertebrate microRNA genes. Science 299: 1540.
16. Rodriguez, A. et al. 2004. Identification of mammalian microRNA host genes and transcription units. Genome Res. 14: 1902-1910.
17. Lee, Y. et al. 2004. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23: 4051-4060.
18. Borchert, G.M., W. Lanier & B.L. Davidson. 2006. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13: 1097-1101.
19. Denli, A.M. et al. 2004. Processing of primary microRNAs by the Microprocessor complex. Nature 432: 231-235.
20. Han, J. et al. 2004. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 18: 3016-3027.
21. Lund, E. et al. 2004. Nuclear export of microRNA precursors. Science 303: 95-98.
22. Yi, R. et al. 2003. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17: 3011-3016.
23. Ketting, R.F. et al. 2001. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15: 2654-2659.
24. Grishok, A. et al. 2001. Genes and mechanisms related to RNAinterference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106: 23-34.
25. Hammond, S.M. et al. 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science 293: 1146-1150.
26. Gregory, R.I. et al. 2005. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123: 631-640.
27. Schwarz, D.S. et al. 2003. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115: 199-208.
28. Yekta, S., I.H. Shih & D.P. Bartel. 2004. MicroRNAdirected cleavage of HOXB8 mRNA. Science 304: 594-596.
29. Du, T. & P.D. Zamore. 2005. microPrimer: The biogenesis and function of microRNA. Development 132: 4645-4652.
30. Filipowicz, W., S.N. Bhattacharyya & N. Sonenberg. 2008. Mechanisms of post-transcriptional regulation by microRNAs: Are the answers in sight? Nat. Rev. Genet. 9: 102-114.
31. Vasudevan, S., Y. Tong & J.A. Steitz. 2007. Switching fromrepression to activation:Micrornas can up-regulate translation. Science 318: 1931-1934.
32. Bhattacharyya, S.N. et al. 2006. Relief of microRNAmediated translational repression in human cells subjected to stress. Cell 125: 1111-1124.
33. Grimson, A. et al. 2007. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol. Cell. 27: 91-105.
34. Von Roretz, C. & I.E. Gallouzi. 2008. Decoding AREmediated decay: Is microRNA part of the equation? J. Cell. Biol. 181: 189-194.
35. Landgraf, P. et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414.
36. Merkerova, M.,M. Belickova & H. Bruchova. 2008. Differential expression of microRNAs in hematopoietic cell lineages. Eur. J. Haematol. 81: 304-310.
37. Kluiver, J. et al. 2006. The role of microRNAs in normal hematopoiesis and hematopoietic malignancies. Leukemia 20: 1931-1936.
38. Merkerova, M.,M. Belickova & H. Bruchova. 2008. Differential expression of microRNAs in hematopoietic cell lineages. Eur. J. Haematol. 81: 304-310.
39. Malumbres, R. et al. 2009. Differentiation-stage-specific expression of microRNAs in B-lymphocytes and diffuse large B-cell lymphomas. Blood 113: 3754-3764.
40. Cattoretti,G. et al. 2006. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J. Immunol. 177: 6930-6939.
41. Warren,A.J. et al. 1994. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78: 45-57.
42. Natkunam, Y. et al. 2007. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 109: 1636-1642.
43. Zhang, J. et al. 2009. Patterns of microRNA expression characterize stages of human B cell differentiation. Blood 113: 4586-4594.
44. Calame, K. 2008. Activation-dependent induction of Blimp-1. Curr. Opin. Immunol. 20: 259-264.
45. Xiao, C. & K. Rajewsky. 2009. MicroRNA control in the immune system: basic principles. Cell 136: 26-36.
46. Monticelli, S. et al. 2005. MicroRNA profiling of the murine hematopoietic system. Genome Biol. 6: R71.
47. Lin, Y.C. et al. 2008. c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development. Mol. Biol. Evol. 25: 2189-2198.
48. Thomas, M.D. et al. 2005. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23: 275-286.
49. Xiao, C. et al. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
50. Lawrie, C.H. et al. 2007. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121: 1156-1161.
51. Chen,C.Z. et al. 2004.MicroRNAsmodulate hematopoietic lineage differentiation. Science 303: 83-86.
52. Stavnezer, J., J.E. Guikema & C.E. Schrader. 2008.Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26: 261-292.
53. de Ýebenes, V.G. et al. 2008. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206.
54. Ota, A. et al. 2004. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res. 64: 3087-3095.
55. Ventura, A. et al. 2008. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886.
56. Egle, A. et al. 2004. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proc. Natl. Acad. Sci. USA 101: 6164-6169.
57. Tam, W. et al. 2002. Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J. Virol. 76: 4275-4286.
58. Tam, W. 2001. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 274: 157-167.
59. Eis, P.S. et al. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102: 3627-3632.
60. Rodriguez, A. et al. 2007. Requirement of bic/ microRNA-155 for normal immune function. Science 316: 608-611.
61. Thai, T.H. et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608.
62. Vigorito, E. et al. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27: 847-859.
63. McKercher, S.R. et al. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15: 5647-5658.
64. Teng, G. et al. 2008.MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28: 621-629.
65. Dorsett, Y. et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28: 630-638.
66. Roehle, A. et al. 2008. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas. Br. J. Haematol. 142: 732-744.
67. Gibcus, J.H. et al. 2009. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11: 167-176.
68. Kluiver, J. et al. 2005. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207: 243-249.
69. Eis, P.S. et al. 2005. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102: 3627-3632.
70. Fulci, V. et al. 2007. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
71. Rai,D. et al. 2008.Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer. Genet. Cytogenet. 181: 8-15.
72. Calin, G.A. et al. 2005. AMicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N. Engl. J. Med. 353: 1793-1801.
73. Jung, I. & R.C. Aguiar. 2009. MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma. Br. J. Haematol. 144: 138-140.
74. Kong, W. et al. 2008. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol. Cell. Biol. 28: 6773-6784.
75. Yin, Q. et al. 2008. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J. Biol. Chem. 283: 2654-2662.
76. Gururajan, M., C.D. Jennings & S. Bondada. 2006. Cutting edge: Constitutive B cell receptor signaling is critical for basal growth of B lymphoma. J. Immunol. 176: 5715-5719.
77. Kluiver, J. et al. 2007. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26: 3769-3776.
78. Davis, R.E. et al. 2001. Constitutive nuclear factor kappaB activity is required for survival of activated B celllike diffuse large B cell lymphoma cells. J. Exp.Med. 194: 1861-1874.
79. Rahadiani, N. et al. 2008. Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem. Biophys. Res. Commun. 377: 579-583.
80. Lu, F. et al. 2008. Epstein-Barr virus-inducedmiR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J. Virol. 82: 10436-10443.
81. Yin, Q. et al. 2008. MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J. Virol. 82: 5295-5306.
82. Costinean, S. et al. 2006. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103: 7024-7029.
83. Calame, K. 2007. MicroRNA-155 function in B Cells. Immunity 27: 825-827.
84. Pasqualucci, L. et al. 2008. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 40: 108-112.
85. Mendell, J.T. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-222.
86. Tagawa, H. & M. Seto. 2005. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19: 2013-2016.
87. He, L. et al. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833.
88. Xiao, C. et al. 2008. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 9: 405-414.
89. O'Donnell,K.A. et al. 2005.c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
90. Sylvestre, Y. et al. 2007. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282: 2135-2143.
91. Woods, K., J.M. Thomson & S.M. Hammond. 2007. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem. 282: 2130-2134.
92. Pickering, M.T., B.M. Stadler & T.F. Kowalik. 2009. miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 28: 140-145.
93. Ivanovska, I. et al. 2008. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol. Cell. Biol. 28: 2167-2174.
94. Inomata, M. et al. 2009. MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113: 396-402.
95. Petrocca, F., A. Vecchione&C.M. Croce. 2008. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 68: 8191-8194.
96. O'Connell, R.M. et al. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104: 1604-1609.
97. Calin, G.A. et al. 2008. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. USA 105: 5166-5171.
98. Jing,Q. et al. 2005. Involvement of microRNAinAU-rich element-mediated mRNA instability. Cell 120: 623-634.
99. Calin, G. et al. 2008.MiR-15a and miR-16-1 cluster functions in human leukemia. Proc. Natl. Acad. Sci. USA 105: 5166-5171.
100. Hao, S. & D. Baltimore. 2009. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat. Immunol. 10: 281-288.